Vivos Therapeutics (VVOS) Competitors $2.10 +0.02 (+0.96%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.10 +0.00 (+0.24%) As of 04/17/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VVOS vs. INO, NTRB, EDAP, MBOT, GUTS, HYPR, SURG, ICAD, APT, and TMDIFShould you be buying Vivos Therapeutics stock or one of its competitors? The main competitors of Vivos Therapeutics include Inovio Pharmaceuticals (INO), Nutriband (NTRB), Edap Tms (EDAP), Microbot Medical (MBOT), Fractyl Health (GUTS), Hyperfine (HYPR), SurgePays (SURG), iCAD (ICAD), Alpha Pro Tech (APT), and Titan Medical (TMDIF). These companies are all part of the "medical equipment" industry. Vivos Therapeutics vs. Inovio Pharmaceuticals Nutriband Edap Tms Microbot Medical Fractyl Health Hyperfine SurgePays iCAD Alpha Pro Tech Titan Medical Inovio Pharmaceuticals (NASDAQ:INO) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Does the MarketBeat Community believe in INO or VVOS? Inovio Pharmaceuticals received 703 more outperform votes than Vivos Therapeutics when rated by MarketBeat users. Likewise, 70.87% of users gave Inovio Pharmaceuticals an outperform vote while only 60.71% of users gave Vivos Therapeutics an outperform vote. CompanyUnderperformOutperformInovio PharmaceuticalsOutperform Votes72070.87% Underperform Votes29629.13% Vivos TherapeuticsOutperform Votes1760.71% Underperform Votes1139.29% Is INO or VVOS more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -86.19%. Inovio Pharmaceuticals' return on equity of -118.17% beat Vivos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -118.17% -83.47% Vivos Therapeutics -86.19%-335.04%-93.58% Do analysts rate INO or VVOS? Inovio Pharmaceuticals currently has a consensus target price of $12.20, suggesting a potential upside of 601.15%. Vivos Therapeutics has a consensus target price of $6.10, suggesting a potential upside of 190.48%. Given Inovio Pharmaceuticals' higher probable upside, equities research analysts plainly believe Inovio Pharmaceuticals is more favorable than Vivos Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Vivos Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor INO or VVOS? In the previous week, Vivos Therapeutics had 3 more articles in the media than Inovio Pharmaceuticals. MarketBeat recorded 5 mentions for Vivos Therapeutics and 2 mentions for Inovio Pharmaceuticals. Vivos Therapeutics' average media sentiment score of -0.07 beat Inovio Pharmaceuticals' score of -0.33 indicating that Vivos Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inovio Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Vivos Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of INO or VVOS? 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 2.5% of Inovio Pharmaceuticals shares are held by insiders. Comparatively, 3.0% of Vivos Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation and earnings, INO or VVOS? Vivos Therapeutics has higher revenue and earnings than Inovio Pharmaceuticals. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$217.76K292.99-$135.12M-$3.99-0.44Vivos Therapeutics$15.03M0.82-$13.58M-$2.91-0.72 Which has more risk & volatility, INO or VVOS? Inovio Pharmaceuticals has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, Vivos Therapeutics has a beta of 7.31, suggesting that its stock price is 631% more volatile than the S&P 500. SummaryInovio Pharmaceuticals and Vivos Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VVOS vs. The Competition Export to ExcelMetricVivos TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.37M$4.04B$5.30B$7.34BDividend YieldN/A39.51%5.12%4.30%P/E Ratio-0.3727.6821.8017.78Price / Sales0.8247.08379.9697.74Price / CashN/A51.0838.2634.64Price / Book9.555.816.443.97Net Income-$13.58M$67.09M$3.21B$247.65M7 Day Performance-9.87%1.98%2.85%1.80%1 Month Performance-40.85%-4.83%-8.64%-6.98%1 Year Performance-21.05%14.48%11.38%1.34% Vivos Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VVOSVivos Therapeutics1.5972 of 5 stars$2.10+1.0%$6.10+190.5%-21.1%$12.37M$15.03M-0.37160Analyst ForecastNews CoverageINOInovio Pharmaceuticals3.263 of 5 stars$1.58+1.3%$12.20+672.2%-84.3%$57.93M$217,756.00-0.40320Analyst UpgradeShort Interest ↑High Trading VolumeNTRBNutriband2.8969 of 5 stars$5.09-5.7%$13.00+155.4%+18.0%$56.53M$2.02M-7.1710Gap DownEDAPEdap Tms2.5659 of 5 stars$1.45-9.9%$8.50+486.2%-81.3%$53.80M$64.12M-2.23230Short Interest ↑MBOTMicrobot Medical1.9513 of 5 stars$1.51+1.3%$9.00+496.0%+176.7%$52.46MN/A-1.8920GUTSFractyl Health1.891 of 5 stars$1.07-4.5%$10.00+834.6%-81.6%$52.34M$93,000.00-0.09102Analyst ForecastNews CoverageHigh Trading VolumeHYPRHyperfine2.8362 of 5 stars$0.65-1.5%$1.33+104.6%-23.5%$50.61M$12.89M-1.14190Short Interest ↑News CoverageSURGSurgePays2.3992 of 5 stars$2.34+0.4%$8.50+263.2%-33.8%$47.76M$60.88M-2.0740Short Interest ↑ICADiCAD0.2348 of 5 stars$1.71-2.3%N/A+106.4%$46.80M$19.61M-13.15140Analyst DowngradeShort Interest ↑News CoverageGap UpAPTAlpha Pro TechN/A$4.30-1.8%N/A-29.2%$46.75M$57.84M11.62120TMDIFTitan MedicalN/A$0.37-5.5%N/A+743.5%$41.76M$17.63M-0.2950Gap Up Related Companies and Tools Related Companies Inovio Pharmaceuticals Competitors Nutriband Competitors Edap Tms Competitors Microbot Medical Competitors Fractyl Health Competitors Hyperfine Competitors SurgePays Competitors iCAD Competitors Alpha Pro Tech Competitors Titan Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VVOS) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VVOS Stock Free VVOS Stock Alerts